LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,210,214 | -33.0% | 53,575 | -19.4% | 0.00% | -50.0% |
| Q2 2023 | $4,792,559 | +0.4% | 66,471 | -0.6% | 0.00% | 0.0% |
| Q1 2023 | $4,772,662 | +4.9% | 66,844 | -1.8% | 0.00% | 0.0% |
| Q4 2022 | $4,549,013 | +22.5% | 68,099 | +57.9% | 0.00% | +33.3% |
| Q3 2022 | $3,714,000 | +1403.6% | 43,130 | +2602.4% | 0.00% | – |
| Q4 2021 | $247,000 | +20.5% | 1,596 | +8.3% | 0.00% | – |
| Q3 2021 | $205,000 | -92.4% | 1,474 | -93.8% | 0.00% | -100.0% |
| Q2 2019 | $2,707,000 | -10.1% | 23,716 | -1.0% | 0.00% | 0.0% |
| Q1 2019 | $3,010,000 | -22.7% | 23,946 | -16.5% | 0.00% | -25.0% |
| Q4 2018 | $3,892,000 | -46.4% | 28,684 | +8.5% | 0.00% | -42.9% |
| Q3 2018 | $7,260,000 | +42.6% | 26,449 | +7.6% | 0.01% | +40.0% |
| Q2 2018 | $5,092,000 | +29.0% | 24,580 | +2.8% | 0.01% | +25.0% |
| Q1 2018 | $3,948,000 | +43.2% | 23,907 | +18.7% | 0.00% | +33.3% |
| Q4 2017 | $2,757,000 | +39.7% | 20,133 | +39.0% | 0.00% | +50.0% |
| Q3 2017 | $1,973,000 | +10.0% | 14,488 | -2.0% | 0.00% | 0.0% |
| Q2 2017 | $1,794,000 | +0.3% | 14,780 | -12.5% | 0.00% | 0.0% |
| Q1 2017 | $1,788,000 | +19.2% | 16,894 | +14.5% | 0.00% | 0.0% |
| Q4 2016 | $1,500,000 | -4.3% | 14,758 | -3.9% | 0.00% | 0.0% |
| Q3 2016 | $1,567,000 | -82.7% | 15,355 | -79.8% | 0.00% | -80.0% |
| Q2 2016 | $9,077,000 | -2.8% | 76,108 | -12.7% | 0.01% | -9.1% |
| Q1 2016 | $9,339,000 | +4.5% | 87,203 | +5.8% | 0.01% | +10.0% |
| Q4 2015 | $8,938,000 | +21.2% | 82,441 | -4.3% | 0.01% | +11.1% |
| Q3 2015 | $7,376,000 | -5.9% | 86,116 | +10.8% | 0.01% | 0.0% |
| Q2 2015 | $7,841,000 | +8.4% | 77,708 | -17.2% | 0.01% | +12.5% |
| Q1 2015 | $7,235,000 | +26.1% | 93,833 | -13.0% | 0.01% | +33.3% |
| Q4 2014 | $5,737,000 | +33.4% | 107,812 | +17.8% | 0.01% | +20.0% |
| Q3 2014 | $4,299,000 | +655.5% | 91,493 | +901.3% | 0.01% | +400.0% |
| Q2 2014 | $569,000 | -7.5% | 9,137 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $615,000 | +151.0% | 9,137 | +96.3% | 0.00% | – |
| Q4 2013 | $245,000 | – | 4,655 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |